Teva reaffirms “pivot to growth” strategy progress with launch of acceleration phase at 2025 innovation and strategy day

Tel aviv, israel and parsippany, n.j., may 29, 2025 (globe newswire) -- teva pharmaceutical industries ltd. (nyse and tase: teva), is hosting today a 2025 innovation & strategy day, to launch the acceleration phase of its “pivot to growth” strategy and to discuss portfolio priorities as it evolves into a global biopharmaceutical leader. the event, led by president and ceo richard francis and members of teva's executive management team, will outline the company's strategy, progress and roadmap to deliver sustained shareholder value through 2030 and beyond.
TEVA Ratings Summary
TEVA Quant Ranking